H. Lundbeck AS (FRA:LDBA) Beginning Cash Position: €459 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LDBA H. Lundbeck AS FRA:LDBA
84 GF Score
Price €5.63
GF Value €6.21
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is H. Lundbeck AS Beginning Cash Position?

H. Lundbeck AS FRA:LDBA -1.83% 84 Beginning Cash Position is €459 Mil as of Mar. 2026. GuruFocus rates FRA:LDBA with a GF Score™ of 84/100 and a GF Value™ of €6.21 (Fairly Valued). The stock has 3 warning signs investors should review.

H. Lundbeck AS's Beginning Cash Position for the quarter that ended in Mar. 2026 was €459 Mil.

H. Lundbeck AS's quarterly Beginning Cash Position increased from Sep. 2025 (€355 Mil) to Dec. 2025 (€466 Mil) but then declined from Dec. 2025 (€466 Mil) to Mar. 2026 (€459 Mil).

H. Lundbeck AS's annual Beginning Cash Position increased from Dec. 2023 (€476 Mil) to Dec. 2024 (€672 Mil) but then declined from Dec. 2024 (€672 Mil) to Dec. 2025 (€624 Mil).

H. Lundbeck AS Beginning Cash Position Related Terms

H. Lundbeck AS Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Beginning Cash Position Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 527.69 306.34 476.02 671.79 624.46

H. Lundbeck AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 625.31 361.52 354.65 465.80 459.31
FRA:LDBA
84GF Score
H. Lundbeck AS FRA:LDBA
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €459 Mil mean?
H. Lundbeck AS (FRA:LDBA) has a Beginning Cash Position of €459 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on H. Lundbeck AS and its competitors.
Is H. Lundbeck AS's Beginning Cash Position too high?
H. Lundbeck AS's current Beginning Cash Position is €459 Mil. Overall, H. Lundbeck AS has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's Beginning Cash Position compare to ZTS and UTHR?
H. Lundbeck AS's Beginning Cash Position of €459 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on H. Lundbeck AS and its competitors. H. Lundbeck AS's current Beginning Cash Position is €459 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (FRA:LDBA) is currently considered Fairly Valued. The stock's GF Value™ is €6.21, compared to a current price of €5.63 — trading 9.4% below its estimated fair value. The current Beginning Cash Position is €459 Mil. H. Lundbeck AS's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For H. Lundbeck AS (FRA:LDBA), the current Beginning Cash Position is €459 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H. Lundbeck AS (FRA:LDBA) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of €5.63 is trading 9.4% below its estimated GF Value™ of €6.21. GuruFocus considers H. Lundbeck AS to be Fairly Valued.

Key valuation signals for FRA:LDBA:

  • Beginning Cash Position: €459 Mil
  • GF Value™: €6.21 vs. price of €5.63 (9.4% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the FRA:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
84GF Score

Get the complete analysis for FRA:LDBA

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.63
Price
€6.21
GF Value